A 6-WEEK STUDY OF THE EFFICACY AND SAFETY OF CICLESONIDE HYDROFLUOROALKANE NASAL AEROSOL IN THE RELIEF OF NASAL SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS

D. Mohar,W. Berger,G. Raphael,C. LaForce,H. Huang,S. Y. Desai,F. Bode

World Allergy Organization Journal（2011）

引用 0|浏览6

暂无评分

摘要

Background Ciclesonide hydrofluoroalkane nasal aerosol (CIC-HFA) is currently in development as a potential treatment for allergic rhinitis. The objective of this study was to determine the efficacy and safety of CIC-HFA compared to placebo in subjects with perennial allergic rhinitis (PAR).

查看译文

关键词

bioinformatics,biomedical research

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要